People

James Boylan

Chief Executive Officer of Enavate Sciences and a member of its board. Previously led investment banking at SVB Leerink and worked in healthcare investment banking at Merrill Lynch, advising life science companies on financing and acquisitions. He also serves on the board of Graviton Bioscience. James Boylan serves as Senior Advisor at Patient Square Capital.